Archives for October 4, 2010

← 2010

ThromboGenics agree ten-year retinal disorder drug deal with MSD Biologics

05-Oct-2010

By Alexandria Pesic

Belgium-based biopharmaceutical company, ThromboGenics, has signed a ten-year supply agreement with MSD Biologics, to produce microplasmin for the treatment of retinal disorders.

RXi and EyeGate’s needle-free ocular RNAi delivery: Part 2

05-Oct-2010

By Alexandria Pesic

RXi and EyeGate lift the lid on ocular delivery of RNAi therapeutics for retinal disorders as the two firm’s team up to provide a unique needle-free solution.